Full Text

Turn on search term navigation

Copyright © 2024 Afsaneh Rahmati et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0/

Abstract

Objective: The successful management of necrotic pulps and apical periodontitis poses a tough challenge in endodontic therapy, as it involves addressing compromised tooth vitality and microbial invasion of root canal systems. Failure to effectively treat these conditions can lead to persistent infection and severe patient discomfort. The efficacy of double antibiotic paste (DAP), a mixture of ciprofloxacin and metronidazole, was evaluated and compared to calcium hydroxide (CH) by assessing radiographic and clinical outcomes of nonsurgical endodontic treatment in cases with necrotic pulps and the presence of apical periodontitis.

Methods: Thirty maxillary anterior teeth with necrotic pulps and apical periodontitis (periapical index [PAI] = 5) were divided randomly into two experimental groups. The first group received CH dressing, while the other group filled with DAP as intracanal medicament. After 3 weeks, medicaments were removed, and teeth were obturated in both groups. Teeth were assessed clinically and radiographically at 6-month and 12-month follow-ups. A chi-square test was performed to compare the outcome between the groups.

Results: None of the teeth showed complete healing in a 6-month follow-up. At the 12-month follow-up, six samples in the DAP group showed complete healing of the periapical (PA) lesion, while none of the samples in the CH group were completely healed. The PA healing outcome was as follows: in the DAP group, 40% of cases were healed, 60% healing, and 0% diseased, while in the CH group, 0% healed, 93.3% healing, and 6.7% diseased. The results of the two experimental groups in 12 months differed significantly (p<0.05).

Conclusion: DAP group has shown significantly better outcomes compared to CH as intracanal medicament in the treatment of teeth with PA lesions. This finding suggests that DAP may offer a more effective therapeutic approach in managing necrotic pulps and apical periodontitis, potentially improving patient outcomes and treatment success rates.

Trial Registration: Clinical Trial Registry identifier: IRCT2015060822615N1

Details

Title
Effect of Calcium Hydroxide Versus Double Antibiotic Paste on Endodontic Treatment Outcomes in Teeth With Large Periapical Lesions: A Triple-Blind Randomized Clinical Trial
Author
Rahmati, Afsaneh 1 ; Seyedein, Farshad 2 ; Dianat, Omid 3   VIAFID ORCID Logo  ; Saedi, Sara 4 ; Rostami, Golriz 4 ; Alireza Akbarzadeh Baghban 5   VIAFID ORCID Logo  ; Shima Sabertahan 6   VIAFID ORCID Logo  ; Majid Kazem 6   VIAFID ORCID Logo 

 Endodontic Department Hamedan University of Medical Sciences Dental School Hamedan Iran 
 Endodontist Private Office Tustin California USA 
 Endodontic Department University of Maryland Dental School Baltimore Maryland USA 
 Endodontist Private Office Tehran Iran 
 Department of Biostatistics Shahid Beheshti University of Medical Sciences Tehran Iran 
 Department of Endodontics Shahid Beheshti University of Medical Sciences Dental School Tehran Iran 
Editor
Kee Y Kum
Publication year
2024
Publication date
2024
Publisher
John Wiley & Sons, Inc.
ISSN
16878728
e-ISSN
16878736
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3151786102
Copyright
Copyright © 2024 Afsaneh Rahmati et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0/